Elligo Health Research brings clinical research to physician practices and accelerate the development of medical device and therapies.
Elligo Health Research has raised $25.0M in total funding. The most recent round was Debt Financing. The last funding was announced in October 2023.
Elligo Health Research's investors include Norwest, Hatteras Venture Partners, Ally Bridge Group, Syneos Health, Morgan Stanley Expansion Capital.
Elligo Health Research is headquartered in Austin, United States.
Elligo Health Research brings clinical research to physician practices and accelerate the development of medical device and therapies.
Elligo Health Research is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Elligo Health Research — Funding & Investors." VCBacked, October 2, 2023, https://www.vcbacked.co/company/elligo-health-research. Accessed September 30, 2026.
VCBacked. (2023). Elligo Health Research — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/elligo-health-research
{{cite web |title=Elligo Health Research — Funding & Investors |url=https://www.vcbacked.co/company/elligo-health-research |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated